-
1
-
-
0141491273
-
Hepatocellular carcinoma
-
DOI 10.1016/S0140-6736(03)14964-1
-
JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 1917 10.1016/S0140-6736(03)14964-1 14667750 (Pubitemid 37518510)
-
(2003)
Lancet
, vol.362
, Issue.9399
, pp. 1907-1917
-
-
Llovet, J.M.1
Burroughs, A.2
Bruix, J.3
-
2
-
-
0036085956
-
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials
-
10.1148/radiol.2241011262 12091661
-
C Cammà F Schepis A Orlando M Albanese L Shahied F Trevisani, et al. 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47 54 10.1148/radiol.2241011262 12091661
-
(2002)
Radiology
, vol.224
, pp. 47-54
-
-
Cammà, C.1
Schepis, F.2
Orlando, A.3
Albanese, M.4
Shahied, L.5
Trevisani, F.6
-
3
-
-
0037308133
-
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
-
DOI 10.1053/jhep.2003.50047
-
JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 10.1053/jhep.2003.50047 1:CAS:528:DC%2BD3sXhsFeltrg%3D 12540794 (Pubitemid 36152543)
-
(2003)
Hepatology
, vol.37
, Issue.2
, pp. 429-442
-
-
Llovet, J.M.1
Bruix, J.2
-
4
-
-
0023857307
-
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial
-
1:STN:280:DyaL1c%2FosVarsA%3D%3D 2826285
-
DY Lin YF Liaw TY Lee CM Lai 1988 Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial Gastroenterology 94 453 456 1:STN:280:DyaL1c%2FosVarsA%3D%3D 2826285
-
(1988)
Gastroenterology
, vol.94
, pp. 453-456
-
-
Lin, D.Y.1
Liaw, Y.F.2
Lee, T.Y.3
Lai, C.M.4
-
5
-
-
0025242359
-
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
-
10.1016/0168-8278(90)90110-D 1:STN:280:DyaK3M%2Fnt12hsQ%3D%3D 2174933
-
G Pelletier A Roche O Ink ML Anciaux S Derhy P Rougier, et al. 1990 A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 181 184 10.1016/0168-8278(90) 90110-D 1:STN:280:DyaK3M%2Fnt12hsQ%3D%3D 2174933
-
(1990)
J Hepatol
, vol.11
, pp. 181-184
-
-
Pelletier, G.1
Roche, A.2
Ink, O.3
Anciaux, M.L.4
Derhy, S.5
Rougier, P.6
-
6
-
-
0029001687
-
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
-
Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire
-
Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256-61.
-
(1995)
N Engl J Med.
, vol.332
, pp. 1256-1261
-
-
-
7
-
-
7144255522
-
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial
-
DOI 10.1016/S0168-8278(98)80187-6
-
G Pelletier M Ducreux F Gay M Luboinski H Hagege T Dao, et al. 1998 Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial J Hepatol 29 129 134 10.1016/S0168-8278(98)80187-6 1:CAS:528:DyaK1cXmvVWhsLk%3D 9696501 (Pubitemid 28307992)
-
(1998)
Journal of Hepatology
, vol.29
, Issue.1
, pp. 129-134
-
-
Pelletier, G.1
Ducreux, M.2
Gay, F.3
Luboinski, M.4
Hagege, H.5
Thong, D.6
Van Steenbergen, W.7
Buffet, C.8
Rougier, P.9
Adler, M.10
Pignon, J.-P.11
Roche, A.12
-
8
-
-
0031801297
-
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
-
DOI 10.1002/hep.510270617
-
J Bruix JM Llovet A Castells X Montana C Bru MC Ayuso, et al. 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution Hepatology 27 1578 1583 10.1002/hep.510270617 1:STN:280:DyaK1c3otFKnsg%3D%3D 9620330 (Pubitemid 28264682)
-
(1998)
Hepatology
, vol.27
, Issue.6
, pp. 1578-1583
-
-
Bruix, J.1
Llovet, J.M.2
Castells, A.3
Montana, X.4
Bru, C.5
Del Carmen Ayuso, M.6
Vilana, R.7
Rodes, J.8
-
9
-
-
0036237822
-
Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma
-
DOI 10.1053/jhep.2002.33156
-
CM Lo H Ngan WK Tso CL Liu CM Lam RT Poon, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 10.1053/jhep.2002.33156 1:CAS:528:DC%2BD38XktF2hu7w%3D 11981766 (Pubitemid 34454013)
-
(2002)
Hepatology
, vol.35
, Issue.5
, pp. 1164-1171
-
-
Lo, C.-M.1
Ngan, H.2
Tso, W.-K.3
Liu, C.-L.4
Lam, C.-M.5
Poon, R.T.-P.6
Fan, S.-T.7
Wong, J.8
-
10
-
-
0037129704
-
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
-
DOI 10.1016/S0140-6736(02)08649-X
-
JM Llovet MI Real X Montana R Planas S Coll J Aponte, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 1739 10.1016/S0140-6736(02)08649-X 12049862 (Pubitemid 34607087)
-
(2002)
Lancet
, vol.359
, Issue.9319
, pp. 1734-1739
-
-
Llovet, J.M.1
Real, M.I.2
Montana, X.3
Planas, R.4
Coll, S.5
Aponte, J.6
Ayuso, C.7
Sala, M.8
Muchart, J.9
Sola, R.10
Rodes, J.11
Bruix, J.12
-
11
-
-
2942601262
-
Therapy for unresectable hepatocellular carcinoma: Review of the randomized clinical trials - II: Systemic and local non-embolization-based therapies in unresectable and advance hepatocellular carcinoma
-
DOI 10.1097/01.cad.0000131140.12228.bb
-
JD Schwartz AS Beutler 2004 Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma Anticancer Drugs 15 439 452 10.1097/01.cad.0000131140.12228.bb 1:CAS:528:DC%2BD2cXktlWqurs%3D 15166617 (Pubitemid 38736941)
-
(2004)
Anti-Cancer Drugs
, vol.15
, Issue.5
, pp. 439-452
-
-
Schwartz, J.D.1
Beutler, A.S.2
-
12
-
-
33845986704
-
Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
-
1:CAS:528:DC%2BD2sXhtleqtrY%3D 17171782
-
M Minagawa M Makuuchi 2006 Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 7561 7567 1:CAS:528:DC%2BD2sXhtleqtrY%3D 17171782
-
(2006)
World J Gastroenterol
, vol.12
, pp. 7561-7567
-
-
Minagawa, M.1
Makuuchi, M.2
-
13
-
-
0027247841
-
Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: Correlation between computed tomography and histopathology
-
10.1007/BF02602962 1:STN:280:DyaK2c%2Fgs1Cisw%3D%3D 8402781
-
T Imaeda Y Yamawaki M Seki H Goto G Iinuma M Kanematsu, et al. 1993 Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology Cardiovasc Intervent Radiol 16 209 213 10.1007/BF02602962 1:STN:280:DyaK2c%2Fgs1Cisw%3D%3D 8402781
-
(1993)
Cardiovasc Intervent Radiol
, vol.16
, pp. 209-213
-
-
Imaeda, T.1
Yamawaki, Y.2
Seki, M.3
Goto, H.4
Iinuma, G.5
Kanematsu, M.6
-
14
-
-
0023197221
-
Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents
-
1:STN:280:DyaL2s7ns1Cjsw%3D%3D 3031724
-
K Takayasu Y Shima Y Muramatsu N Moriyama T Yamada M Makuuchi, et al. 1987 Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163 345 351 1:STN:280: DyaL2s7ns1Cjsw%3D%3D 3031724
-
(1987)
Radiology
, vol.163
, pp. 345-351
-
-
Takayasu, K.1
Shima, Y.2
Muramatsu, Y.3
Moriyama, N.4
Yamada, T.5
Makuuchi, M.6
-
15
-
-
0034071842
-
Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma
-
10.1159/000012115 1:STN:280:DC%2BD3c3pvFajtQ%3D%3D 10838494
-
T Okusaka S Okada H Ueno M Ikeda M Yoshimori K Shimada, et al. 2000 Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma Oncology 58 293 299 10.1159/000012115 1:STN:280:DC%2BD3c3pvFajtQ%3D%3D 10838494
-
(2000)
Oncology
, vol.58
, pp. 293-299
-
-
Okusaka, T.1
Okada, S.2
Ueno, H.3
Ikeda, M.4
Yoshimori, M.5
Shimada, K.6
-
16
-
-
77949263981
-
Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: Results of a multicenter randomized phase III trial
-
abstr 4643
-
Okusaka T, Sato T, Hinotsu S, Shioyama Y, Kasugai H, Tanaka K, et al. Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: results of a multicenter randomized phase III trial. J Clin Oncol 2007 ASCO Annual Meeting Proceedings. 2007;25:18S (abstr 4643).
-
(2007)
J Clin Oncol 2007 ASCO Annual Meeting Proceedings
, vol.25
-
-
Okusaka, T.1
Sato, T.2
Hinotsu, S.3
Shioyama, Y.4
Kasugai, H.5
Tanaka, K.6
-
17
-
-
1642525643
-
Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma
-
DOI 10.1159/000076331
-
M Ikeda S Maeda J Shibata R Muta H Ashihara M Tanaka, et al. 2004 Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma Oncology 66 24 31 10.1159/000076331 1:CAS:528:DC%2BD2cXitlyitLo%3D 15031595 (Pubitemid 38410676)
-
(2004)
Oncology
, vol.66
, Issue.1
, pp. 24-31
-
-
Ikeda, M.1
Maeda, S.2
Shibata, J.3
Muta, R.4
Ashihara, H.5
Tanaka, M.6
Fujiyama, S.7
Tomita, K.8
-
18
-
-
18444381151
-
Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma
-
DOI 10.1159/000059570
-
T Okusaka S Okada H Ueno M Ikeda R Iwata H Furukawa, et al. 2002 Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma Oncology 62 228 233 10.1159/000059570 1:CAS:528:DC%2BD38Xlt1yls7g%3D 12065870 (Pubitemid 34639056)
-
(2002)
Oncology
, vol.62
, Issue.3
, pp. 228-233
-
-
Okusaka, T.1
Okada, S.2
Ueno, H.3
Ikeda, M.4
Iwata, R.5
Furukawa, H.6
Takayasu, K.7
Moriyama, N.8
Sato, T.9
Sato, K.10
-
19
-
-
20444431241
-
Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
-
DOI 10.1007/s00535-004-1494-7
-
T Yamasaki T Kimura F Kurokawa K Aoyama T Ishikawa K Tajima, et al. 2005 Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy J Gastroenterol 40 70 78 10.1007/s00535-004-1494-7 1:CAS:528:DC%2BD2MXhtVamsbo%3D 15692792 (Pubitemid 40796335)
-
(2005)
Journal of Gastroenterology
, vol.40
, Issue.1
, pp. 70-78
-
-
Yamasaki, T.1
Kimura, T.2
Kurokawa, F.3
Aoyama, K.4
Ishikawa, T.5
Tajima, K.6
Yokoyama, Y.7
Takami, T.8
Omori, K.9
Kawaguchi, K.10
Tsuchiya, M.11
Terai, S.12
Sakaida, I.13
Okita, K.14
-
20
-
-
35448994259
-
Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma
-
DOI 10.1007/s00535-007-2099-8
-
K Uka H Aikata S Takaki D Miki T Kawaoka SC Jeong, et al. 2007 Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma J Gastroenterol 42 845 853 10.1007/s00535-007-2099-8 1:CAS:528:DC%2BD2sXhtFyrur3L 17940838 (Pubitemid 47617463)
-
(2007)
Journal of Gastroenterology
, vol.42
, Issue.10
, pp. 845-853
-
-
Uka, K.1
Aikata, H.2
Takaki, S.3
Miki, D.4
Kawaoka, T.5
Jeong, S.C.6
Takahashi, S.7
Toyota, N.8
Ito, K.9
Chayama, K.10
-
21
-
-
42649086177
-
Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma
-
DOI 10.1111/j.1872-034X.2008.00338.x
-
M Yoshikawa N Ono H Yodono T Ichida H Nakamura 2008 Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma Hepatol Res 38 474 483 10.1111/j.1872-034X.2008.00338. x 1:CAS:528:DC%2BD1cXptlajsLw%3D 18430093 (Pubitemid 351593948)
-
(2008)
Hepatology Research
, vol.38
, Issue.5
, pp. 474-483
-
-
Yoshikawa, M.1
Ono, N.2
Yodono, H.3
Ichida, T.4
Nakamura, H.5
-
22
-
-
0033972909
-
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
-
DOI 10.1002/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I
-
L Lladó J Virgili J Figueras C Valls J Dominguez A Rafecas, et al. 2000 A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 50 57 10.1002/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I 10618605 (Pubitemid 30027678)
-
(2000)
Cancer
, vol.88
, Issue.1
, pp. 50-57
-
-
Llado, L.1
Virgili, J.2
Figueras, J.3
Valls, C.4
Dominguez, J.5
Rafecas, A.6
Torras, J.7
Fabregat, J.8
Guardiola, J.9
Jaurrieta, E.10
-
23
-
-
0036832619
-
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization
-
DOI 10.1093/jjco/hyf097
-
M Ikeda S Okada S Yamamoto T Sato H Ueno T Okusaka, et al. 2002 Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization Jpn J Clin Oncol 32 455 460 10.1093/jjco/hyf097 12499417 (Pubitemid 43102766)
-
(2002)
Japanese Journal of Clinical Oncology
, vol.32
, Issue.11
, pp. 455-460
-
-
Ikeda, M.1
Okada, S.2
Yamamoto, S.3
Sato, T.4
Ueno, H.5
Okusaka, T.6
Kuriyama, H.7
Takayasu, K.8
Furukawa, H.9
Iwata, R.10
-
24
-
-
40449095328
-
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: Prognostic features, treatment outcome, and survival
-
DOI 10.1007/s00535-007-2134-9
-
CS Changchien CL Chen YH Yen JH Wang TH Hu CM Lee, et al. 2008 Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival J Gastroenterol 43 159 170 10.1007/s00535-007-2134-9 1:CAS:528:DC%2BD1cXislSjs7c%3D 18306990 (Pubitemid 351344558)
-
(2008)
Journal of Gastroenterology
, vol.43
, Issue.2
, pp. 159-170
-
-
Changchien, C.-S.1
Chen, C.-L.2
Yen, Y.-H.3
Wang, J.-H.4
Hu, T.-H.5
Lee, C.-M.6
Wang, C.-C.7
Cheng, Y.-F.8
Huang, Y.-J.9
Lin, C.-Y.10
Lu, S.-N.11
-
25
-
-
0024468181
-
Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma
-
10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E 1:STN:280:DyaK3c%2Fgt1Onsw%3D%3D 2477131
-
J Shibata S Fujiyama T Sato S Kishimoto S Fukushima M Nakano 1989 Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma Cancer 64 1586 1594 10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E 1:STN:280:DyaK3c%2Fgt1Onsw%3D%3D 2477131
-
(1989)
Cancer
, vol.64
, pp. 1586-1594
-
-
Shibata, J.1
Fujiyama, S.2
Sato, T.3
Kishimoto, S.4
Fukushima, S.5
Nakano, M.6
-
26
-
-
0028220635
-
A randomized trial of intrahepatic arterial infusion of 4?-epidoxorubicin with lipiodol versus 4?-epidoxorubicin alone in the treatment of hepatocellular carcinoma
-
10.1007/BF00686689 8137478
-
M Yoshikawa H Saisho M Ebara T Iijima S Iwama F Endo, et al. 1994 A randomized trial of intrahepatic arterial infusion of 4?-epidoxorubicin with lipiodol versus 4?-epidoxorubicin alone in the treatment of hepatocellular carcinoma Cancer Chemother Pharmacol 33 Suppl S149 S152 10.1007/BF00686689 8137478
-
(1994)
Cancer Chemother Pharmacol
, vol.33
, Issue.SUPPL
-
-
Yoshikawa, M.1
Saisho, H.2
Ebara, M.3
Iijima, T.4
Iwama, S.5
Endo, F.6
-
27
-
-
1442277082
-
Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma
-
DOI 10.1023/B:DRUG.0000011793.72775.d1
-
T Okusaka S Okada T Nakanishi S Fujiyama Y Kubo 2004 Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma Invest New Drugs 22 169 176 10.1023/B:DRUG.0000011793.72775.d1 1:CAS:528:DC%2BD2cXisleitg%3D%3D 14739665 (Pubitemid 38270472)
-
(2004)
Investigational New Drugs
, vol.22
, Issue.2
, pp. 169-176
-
-
Okusaka, T.1
Okada, S.2
Nakanishi, T.3
Fujiyama, S.4
Kubo, Y.5
-
28
-
-
0021965806
-
Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
-
DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0. CO;2-E
-
K Okuda T Ohtsuki H Obata M Tomimatsu N Okazaki H Hasegawa, et al. 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928 10.1002/1097-0142(19850815) 56:4<918::AID-CNCR2820560437>3.0.CO;2-E 1:STN:280:DyaL2M3lsVaqtw%3D%3D 2990661 (Pubitemid 15228292)
-
(1985)
Cancer
, vol.56
, Issue.4
, pp. 918-928
-
-
Okuda, K.1
Ohtsuki, T.2
Obata, H.3
-
29
-
-
0015854966
-
Transection of the oesophagus for bleeding oesophageal varices
-
10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D 4541913
-
RNH Pugh IM Murry-Lyon JL Dawson MC Pietroni R Williams 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D 4541913
-
(1973)
Br J Surg
, vol.60
, pp. 646-649
-
-
Pugh, R.N.H.1
Murry-Lyon, I.M.2
Dawson, J.L.3
Pietroni, M.C.4
Williams, R.5
-
30
-
-
46949099956
-
Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma
-
DOI 10.1007/s00535-008-2164-y
-
KZ Luo T Itamoto H Amano A Oshita Y Ushitora Y Tanimoto, et al. 2008 Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma J Gastroenterol 43 369 377 10.1007/s00535-008-2164-y 1:CAS:528: DC%2BD1cXns1egu7g%3D 18592155 (Pubitemid 351958901)
-
(2008)
Journal of Gastroenterology
, vol.43
, Issue.5
, pp. 369-377
-
-
Luo, K.-Z.1
Itamoto, T.2
Amano, H.3
Oshita, A.4
Ushitora, Y.5
Tanimoto, Y.6
Ohdan, H.7
Tashiro, H.8
Asahara, T.9
-
31
-
-
47949116252
-
SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma
-
10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
-
JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
|